Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke

J Montaner, L Ramiro, A Simats, S Tiedt… - Nature Reviews …, 2020 - nature.com
Despite many years of research, no biomarkers for stroke are available to use in clinical
practice. Progress in high-throughput technologies has provided new opportunities to …
被引用次数：204 相关文章

Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke.

J Montaner, L Ramiro, A Simats, S Tiedt… - Nature reviews …, 2020 - sonar.ch
English Despite many years of research, no biomarkers for stroke are available to use in
clinical practice. Progress in high-throughput technologies has provided new opportunities …

[引用][C] Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke

J Montaner, L Ramiro, A Simats, S Tiedt… - Nature Reviews …, 2020 - cir.nii.ac.jp

Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke

J Montaner, L Ramiro Pascual, A Simats, S Tiedt… - 2020 - digital.csic.es
Despite many years of research, no biomarkers for stroke are available to use in clinical
practice. Progress in high-throughput technologies has provided new opportunities to …

Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke.

J Montaner, L Ramiro, A Simats, S Tiedt… - Nature reviews …, 2020 - europepmc.org
Despite many years of research, no biomarkers for stroke are available to use in clinical
practice. Progress in high-throughput technologies has provided new opportunities to …

Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke

J Montaner, R Laura, S Alba, T Steffen… - Nature Reviews …, 2020 - search.proquest.com
Despite many years of research, no biomarkers for stroke are available to use in clinical
practice. Progress in high-throughput technologies has provided new opportunities to …

Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke

J Montaner, L Ramiro, A Simats… - Nature reviews …, 2020 - pubmed.ncbi.nlm.nih.gov
Despite many years of research, no biomarkers for stroke are available to use in clinical
practice. Progress in high-throughput technologies has provided new opportunities to …

Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke

J Montaner, L Ramiro, A Simats… - Nature Reviews …, 2020 - epub.ub.uni-muenchen.de
Despite many years of research, no biomarkers for stroke are available to use in clinical
practice. Progress in high-throughput technologies has provided new opportunities to …

Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke

J Montaner, L Ramiro, A Simats, S Tiedt… - Nature Reviews …, 2020 - hal.science
Despite many years of research, no biomarkers for stroke are available to use in clinical
practice. Progress in high-throughput technologies has provided new opportunities to …

Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke

J Montaner, R Laura, S Alba, T Steffen… - Nature Reviews …, 2020 - search.proquest.com
Despite many years of research, no biomarkers for stroke are available to use in clinical
practice. Progress in high-throughput technologies has provided new opportunities to …